343 related articles for article (PubMed ID: 24861649)
1. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).
Thiel J; Rattray D; Cher DJ
J Minim Invasive Gynecol; 2014; 21(6):1055-60. PubMed ID: 24861649
[TBL] [Abstract][Full Text] [Related]
2. One-step transvaginal three-dimensional hysterosalpingo-foam sonography (3D-HyFoSy) confirmation test for Essure® follow-up: a multicenter study.
Zizolfi B; Lazzeri L; Franchini M; Di Spiezio Sardo A; Nappi C; Piccione E; Exacoustos C
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):134-141. PubMed ID: 28067009
[TBL] [Abstract][Full Text] [Related]
3. Use of Hysterosalpingo-Foam Sonography for Assessment of the Efficacy of Essure Hysteroscopic Sterilization.
Rosič M; Žegura B; Vadnjal Đonlagić S
J Ultrasound Med; 2018 Aug; 37(8):1929-1935. PubMed ID: 29344973
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tubal patency after essure placement.
Rodriguez AM; Kilic GS; Vu TP; Kuo YF; Breitkopf D; Snyder RR
J Minim Invasive Gynecol; 2013; 20(4):468-72. PubMed ID: 23541247
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges.
Dreyer K; Hompes PG; Mijatovic V
Reprod Biomed Online; 2015 Apr; 30(4):421-5. PubMed ID: 25682307
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative Factors that Predict the Successful Placement of Essure Microinserts.
Arthuis CJ; Simon EG; Hébert T; Marret H
J Minim Invasive Gynecol; 2017; 24(5):803-810. PubMed ID: 28390945
[TBL] [Abstract][Full Text] [Related]
7. Algorithm of Transvaginal Ultrasound and/or Hysterosalpingogram for Confirmation Testing at 3 Months after Essure Placement.
Vleugels M; Cheng RF; Goldstein J; Bangerter K; Connor V
J Minim Invasive Gynecol; 2017; 24(7):1128-1135. PubMed ID: 28669895
[TBL] [Abstract][Full Text] [Related]
8. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
[TBL] [Abstract][Full Text] [Related]
9. Post-Essure hysterosalpingography compliance in a clinic population.
Shavell VI; Abdallah ME; Diamond MP; Kmak DC; Berman JM
J Minim Invasive Gynecol; 2008; 15(4):431-4. PubMed ID: 18588851
[TBL] [Abstract][Full Text] [Related]
10. Contrast infusion sonography in the post-Essure setting.
Connor V
J Minim Invasive Gynecol; 2008; 15(1):56-61. PubMed ID: 18262145
[TBL] [Abstract][Full Text] [Related]
11. Essure insert expulsion after 3-month hysterosalpingogram confirmation of bilateral tubal occlusion and bilateral correct placement: case report.
Garcia AL; Lewis RM; Sloan AL
J Minim Invasive Gynecol; 2013; 20(1):107-11. PubMed ID: 23312251
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound assessment of the Essure contraceptive devices: is three-dimensional ultrasound really needed?
Paladini D; Di Spiezio Sardo A; Coppola C; Zizolfi B; Pastore G; Nappi C
J Minim Invasive Gynecol; 2015 Jan; 22(1):115-21. PubMed ID: 25241073
[TBL] [Abstract][Full Text] [Related]
13. Hysteroscopic Sterilization Device Follow-Up Rate: Hysterosalpingogram Versus Transvaginal Ultrasound.
Jeirath N; Basinski CM; Hammond MA
J Minim Invasive Gynecol; 2018; 25(5):836-841. PubMed ID: 29289623
[TBL] [Abstract][Full Text] [Related]
14. Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
Karthigasu KA; Garry R; Hart R
Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):365-7. PubMed ID: 16866803
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine fluid instillation to confirm tubal occlusion after transcervical permanent contraception: A pilot study
Patil E; Thurmond A; Hart K; Seguin J; Edelman A; Jensen JT
Contraception; 2020 Jan; 101(1):40-45. PubMed ID: 31655066
[TBL] [Abstract][Full Text] [Related]
16. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study.
Kerin JF; Carignan CS; Cher D
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):364-70. PubMed ID: 11787907
[TBL] [Abstract][Full Text] [Related]
17. Assessment of three-dimensional ultrasound examination classification to check the position of the tubal sterilization microinsert.
Legendre G; Gervaise A; Levaillant JM; Faivre E; Deffieux X; Fernandez H
Fertil Steril; 2010 Dec; 94(7):2732-5. PubMed ID: 20451183
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study.
Chudnoff SG; Nichols JE; Levie M
J Minim Invasive Gynecol; 2015; 22(6):951-60. PubMed ID: 25917278
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging three-dimensional ultrasound.
Thiel JA; Suchet IB; Lortie K
Fertil Steril; 2005 Aug; 84(2):504-8. PubMed ID: 16084897
[TBL] [Abstract][Full Text] [Related]
20. Contrast infusion sonography to assess microinsert placement and tubal occlusion after Essure.
Connor VF
Fertil Steril; 2006 Jun; 85(6):1791-3. PubMed ID: 16650420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
